Claims
- 1-15. (cancelled)
- 16. A composition comprising hydrolyzed exopolysaccharide YAS34.
- 17. The composition according to claim 16, wherein the EPS YAS34 is hydrolyzed to an average molecular weight range from 500,000 to 10,000.
- 18. The composition according to claim 17, wherein the hydrolyzed YAS34 has an average molecular weight of 45,000.
- 19. The composition according to claim 16, further comprising a settling agent.
- 20. The composition according to claim 19, wherein the setting agent is selected from the group consisting of carrageenan, gellan gum, pectin, agorose, gelatin, xanthan with locust bean gum, xanthan with konjac, native EPS YAS34, and mixtures thereof.
- 21. The composition according to claim 19, wherein the setting agent is contained in an amount of 0.5 to 15% by weight of the composition.
- 22. The composition according to claim 19, wherein the setting agent further comprises a salt of a mono or divalent cation.
- 23. The composition according to claim 22, wherein the cation salt is contained in an amount of 0.01 to 5% by weight of the composition.
- 24. A container for unit dosage forms comprising the composition according to claim 16.
- 25. An aqueous solution comprising the composition according to claim 16.
- 26. The aqueous solution according to claim 25, containing hydrolyzed EPS YAS34 in an amount of 10 to 50%, by weight of the aqueous solution.
- 27. The aqueous solution according to claim 26, containing hydrolyzed EPS YAS34 in an amount of 15 to 40%, by weight of the aqueous solution.
- 28. The aqueous solution according to claim 25, further comprising a setting agent in an amount of 0.01 to 5%, by weight of the aqueous solution.
- 29. The aqueous solution according to claim 28, containing hydrolyzed EPS YAS34 in an amount of 0.03 to 3%, by weight of the aqueous solution.
- 30. The aqueous solution according to claim 28, further comprising a salt of a mono or divalent cation in an amount of 0.01 to 3%, by weight of the aqueous solution.
- 31. The aqueous solution according to claim 30, further comprising a salt of a mono or divalent cation in an amount of 0.01 to 1%, by weight of the aqueous solution.
Priority Claims (1)
Number |
Date |
Country |
Kind |
00402437.8 |
Sep 2000 |
EP |
|
Parent Case Info
[0001] “This application claims priority under 35 U.S.C. § 120 to U.S. application Ser. No. 10/344,117, filed Feb. 6, 2003 which claimed priority to PCT/EP01/09593, filed Aug. 21, 2001 and European Patent Application 00402437.8, filed Sep. 5, 2000.”
Continuations (1)
|
Number |
Date |
Country |
Parent |
10344117 |
Feb 2003 |
US |
Child |
10868302 |
Jun 2004 |
US |